PATAGONIA PHARMACEUTICALS LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.patagoniarx.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis
Phase 2
Completed
- Conditions
- Congenital Ichthyosis
- Interventions
- Drug: PAT-001, 0.1%Drug: PAT-001, 0.2%Drug: Vehicle for PAT-001 0.1%Drug: Vehicle for PAT-001 0.2%
- First Posted Date
- 2016-08-11
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Patagonia Pharmaceuticals, LLC
- Target Recruit Count
- 19
- Registration Number
- NCT02864082
- Locations
- 🇺🇸
TCR Medical Corporation, San Diego, California, United States
🇺🇸Yale Center for Clinical Investigation, New Haven, Connecticut, United States
🇺🇸Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
News
No news found